Select Page

Healthy Eyes through AI

November 16, 2018  · 2 min read

Google is partnering with ophthalmologists in India to use an artificial intelligence (AI) algorithm to improve diabetes care and prevent vision loss by increasing the speed and accessibility of the diagnostic process. AI has already been validated as a screening tool for diabetes-related vision complications such as diabetic retinopathy (DR) in the US, and this project is investigating whether similar technology could be used in India to improve patient care and diabetes management.

Why is DR a growing concern?

People are living longer with diabetes, and with longer duration of the disease comes the increased likelihood of damage to blood vessels and nerves from long-term high blood glucose levels. This damage can be observed throughout the body, including the eyes.

Fortunately, vision loss is preventable with early diagnosis of DR, followed by timely treatment and improved diabetes management (i.e. healthy diet, physical activity, and maintenance of blood pressure). To learn more the prevention of diabetes complications and whether new diagnostic technologies are effective, contact Prof. Dr. Hans-Peter Hammes, a world-renowned leader in endocrinological research.

What is AI?

The innovation and technology space is notorious for its use of jargon – so what does it all actually mean? According to ScienceDaily, AI refers to ‘"the study and design of intelligent agents" where an intelligent agent is a system that perceives its environment and takes actions which maximizes its chances of success.’ Basically, AI is any machine that can learn and problem solve.

How else can AI help improve functional ability and healthy ageing at the population level? Get an expert perspective from Prof. Suzanne Martin, a Professor of Occupational Therapy from Belfast, Northern Ireland whose research focus is on new and emerging technologies in health and social care.

Featured Experts:
Other Experts:
  • a

    Dr. Endre Ludwig

    Adult Vaccination
    Clinical Pharmacology
    Pneumococcal Vaccines
  • a

    Dr. César Misael Gómez Altamirano

  • a

    Dr. José-Luis Díaz-Ortega

    Infant Mortality
  • a

    Gary Finnegan

    Media Relations
    Social Media
    Strategic Communications
  • a

    Parvaiz A. Koul

    Chronic Obstructive Pulmonary Disease
    Infectious Disease Epidemiology
    Immunology of Infectious Diseases
    Renal Tubular Acidosis
    Emerging Infectious Diseases
View More

Recent Articles

Happy Holiday!

IFA would like to thank you for your support in 2019. We wish you a happy holiday and all the best for the new year.
Please note that our office will be closed from 24 December 2019 to 2 January 2020. If you have any inquiry, please contact Dr Jane Barratt at

Share This